ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p456.xmlMyelodysplastic Syndromes Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p473.xmlNovel Biospecific Agents for the Treatment of Myelodysplastic Syndromes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p473.pdf2026-04-18Novel Biospecific Agents for the Treatment of Myelodysplastic Syndromeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p482.xmlChronic Myelogenous Leukemia Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p501.xmlNew Agents in Chronic Myelogenous Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p501.pdf2026-04-18New Agents in Chronic Myelogenous Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p513.xmlHow to Monitor Patients with Chronic Myelogenous Leukemia2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p513.pdf2026-04-18How to Monitor Patients with Chronic Myelogenous Leukemiahttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/4/article-p520.xmlAcute Myeloid Leukemia Clinical Practice Guidelines in Oncology2026-04-18